Table 1.

Baseline Characteristics

	Control Group (n=11)	VR-JIT Group (n=21)	p-value
Demographics
Age, mean years (SD)	39.1 (10.6)	40.8 (12.2)	0.76
Gender (% male)	54.5%	52.4%	0.34
Parental education, mean years (SD)	11.7 (1.8)	12.9 (3.4)	0.46
Race
% Caucasian	27.3%	28.6%
% African-American	54.5%	66.7%	0.29
% Latino	18.2%	4.8%
Vocational history
Months since prior employment, mean (SD)a	26.9 (41.0)	65.2 (92.4)	0.27
Prior full-time employment (%)	63.6%	71.4%	0.87
Prior paid employment (any type) (%)	100%	95.2%	0.53
Prior participation in vocational training program	27.3%	38.1%	0.37
Cognitive function
Neurocognition, mean (SD)	72.5 (12.6)	74.8 (16.4)	0.76
Basic social cognition, mean (SD)	0.71 (0.2)	0.69 (0.1)	0.67
Advanced social cognition, mean (SD)	0.77 (0.1)	0.74 (0.1)	0.88
Clinical history
Duration of illness, mean years (SD)	16.0 (11.4)	19.5 (11.2)	0.41
Clinical symptoms
Hallucinations	2.36 (2.1)	1.71 (1.8)	0.34
Delusions	2.36 (2.1)	2.50 (1.9)	0.88
Bizarre behavior	0.36 (0.8)	0.95 (1.2)	0.24
Thought disorder	1.18 (1.3)	0.90 (1.3)	0.56
Affective flattening	1.64 (1.4)	1.86 (1.6)	0.73
Alogia	1.27 (1.3)	1.14 (1.5)	0.79
Avolitionb	2.90 (0.8)	2.90 (1.1)	0.86
Anhedoniac	2.38 (1.6)	3.73 (1.4)	0.05
Attentionc	1.75 (0.9)	2.00 (1.5)	0.73
Chlorpromazine equivalent	245.25 (164.9)	340.81 (197.9)	0.18
Treated with atypical antipsychotic medication	81.8%	90.0%
Treated with typical antipsychotic medication	18.2%	10.0%	0.52

^atwo outliers excluded for VR-JIT trainees: 324 months and 276 months;

^bone VR-JIT trainee was not rated on this domain;

^cthree controls and six VR-JIT trainees were not rated on this domain